This journal publishes scholarly reviews and experimental papers that address the state of the art in the management of allergic and immunologic diseases and in particular place newly available data into perspective. Each issue of the journal is devoted to a single theme of critical importance to allergists and immunologists, with the goal of providing a comprehensive treatment of the subject that will benefit a wide readership. Readers will find the journal of value in elucidating the impact of novel data on clinical management against the background of advances such as the development of standardized protocols for allergy skin testing and challenge procedures and improved understanding of cell biology. The ultimate objective is to help improve the care and management of patients with immune-mediated disease.
- Tracks advances in the clinical management of both allergic and immunologic diseases, including autoimmunity
- Publishes in-depth reviews and also experimental papers that are of broad interest to immunologists and include a detailed review of the literature
- Each issue is devoted to a single theme, providing a comprehensive overview of a subject important to allergists and immunologists
Journal information
- Editor-in-Chief
-
- M. Eric Gershwin
- Publishing model
- Hybrid. Learn about publishing Open Access with us
Journal metrics
- 6.437 (2019)
- Impact factor
- 5.877 (2019)
- Five year impact factor
- 16 days
- Submission to first decision
- 56 days
- Submission to acceptance
- 179,899 (2019)
- Downloads
Latest issue

Volume 60
Current concepts in rheumatological diseases
Latest articles
-
-
Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review
Authors (first, second and last of 5)
-
Pathophysiology of Hereditary Angioedema (HAE) Beyond the SERPING1 Gene
Authors (first, second and last of 7)
-
-
Current and Prospective Targets of Pharmacologic Treatment of Hereditary Angioedema Types 1 and 2
Authors
Journal updates
-
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
About this journal
- Electronic ISSN
- 1559-0267
- Abstracted and indexed in
-
- AGRICOLA
- CAB Abstracts
- CNKI
- Chemical Abstracts Service (CAS)
- Current Contents/ Life Sciences
- Current Contents/Clinical Medicine
- Dimensions
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EMBASE
- Gale
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Agricultural & Environmental Science Database
- ProQuest Algology, Mycology and Protozoology Abstracts (Microbiology C)
- ProQuest Bacteriology Abstracts (Microbiology B)
- ProQuest Biological Science Database
- ProQuest Central
- ProQuest Environmental Science
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Immunology Abstracts
- ProQuest Industrial and Applied Microbiology Abstracts (Microbiology A)
- ProQuest Medical Database
- ProQuest Natural Science Collection
- ProQuest Pharma Collection
- ProQuest SciTech Premium Collection
- ProQuest Toxicology Abstracts
- ProQuest Virology and AIDS Abstracts
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Qinsight
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index
- Science Citation Index Expanded (SciSearch)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information
-
© Springer Science+Business Media, LLC, part of Springer Nature